CLTA antibody (AA 141-190)

Catalog No. ABIN6755346

Product Details anti-CLTA Antibody

Target: CLTA (Clathrin, Light Chain A (CLTA))

Binding Specificity: AA 141-190

Reactivity: Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit, Bat, Monkey, Pig

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CLTA antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Brand: IHC-plus™

Specificity: Human CLTA

Purification: Immunoaffinity purified

Immunogen: Synthetic peptide located between aa141-190 of human CLTA (P09496, NP_001824). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Marmoset, Mouse, Rat, Elephant, Dog, Bovine, Bat, Rabbit, Horse, Pig, Guinea pig (100%), Panda, Opossum, Turkey, Chicken, Xenopus, Stickleback (92%), Platypus (85%), Zebra finch (84%), Salmon (83%).

Type of Immunogen: Synthetic peptide

Application Details

Application Notes: Approved: IHC, IHC-P (10 μg/mL), WB (0.2 - 1 μg/mL)

Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Distilled water

Concentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Handling Advice: Avoid repeat freeze-thaw cycles.

Storage: 4 °C,-20 °C

Storage Comment: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Target Details for CLTA

Target: CLTA (Clathrin, Light Chain A (CLTA))

Alternative Name: CLTA / LCA (CLTA Products)

Background: Name/Gene ID: CLTA

Synonyms: CLTA, Clathrin light chain A, Clathrin, light chain A, LCA

Gene ID: 1211

NCBI Accession: NP_001824

Pathways: EGFR Signaling Pathway, Neurotrophin Signaling Pathway, EGFR Downregulation